aid: abiomed
name: Abiomed
description: >-
  Abiomed is a Danvers, Massachusetts medical device manufacturer and, since December 22 2022, a
  standalone business inside Johnson & Johnson MedTech, which acquired it for approximately $16.6
  billion. The company designs, manufactures and supports the Impella family of percutaneous
  micro-axial heart pumps — Impella CP, 5.5, RP Flex and the SmartAssist sensor line — used for
  temporary mechanical circulatory support during high-risk percutaneous coronary intervention and
  in cardiogenic shock, alongside the Automated Impella Controller console, the Breethe OXY-1 ECMO
  system and the Impella Connect remote case-review service. Its product is regulated hardware sold
  to hospitals and cath labs, supported by a 24/7 clinical support centre, not software sold to
  developers. Abiomed's digital surface is limited to two end-user products: Impella Connect, a
  customer-only clinician portal that receives one-way RTMPS video of the console screen over port
  443, and the Impella App for clinical reference. Abiomed publishes no developer portal, no API
  reference, no OpenAPI or other machine-readable specification, no SDK on npm, PyPI or any other
  registry, and maintains no public source-code organisation; the corporate site abiomed.com now
  redirects to the brand site at heartrecovery.com.
url: https://raw.githubusercontent.com/api-evangelist/abiomed/refs/heads/main/apis.yml
image: https://www.heartrecovery.com/themes/heartrecovery_theme/heartrecovery/logo-jjmt-main.svg
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline
x-parent-company: Johnson & Johnson
specificationVersion: '0.23'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Medical Devices
- Health Care
- Cardiology
- Mechanical Circulatory Support
- Heart Pumps
- Medical Technology
- Hospitals
- Clinical Support
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abiomed-domain-security.yml
- type: Website
  url: https://www.heartrecovery.com/en-us
- type: Support
  url: https://www.heartrecovery.com/en-us/contact-us
- type: TermsOfService
  url: https://www.heartrecovery.com/en-us/terms-of-use
- type: PrivacyPolicy
  url: https://www.heartrecovery.com/en-us/privacy-policy
- type: Login
  url: https://www.impellaconnect.com/
- type: SecondaryMarket
  url: https://forgeglobal.com/abiomed_stock/
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 2
  pass: local-v3
x-coverage:
  state: none
  reason: no-developer-program
  detail: >-
    Abiomed sells regulated cardiac hardware — the Impella heart-pump family and its Automated
    Impella Controller console — and its only software is two end-user products with no developer
    surface: the customer-only Impella Connect clinician portal, whose Angular SPA catch-all
    answers HTTP 200 with the same HTML shell for /openapi.json, /swagger.json, /llms.txt and every
    /.well-known/* path, and the Impella App; abiomed.com 301s to www.heartrecovery.com, whose
    375-URL sitemap contains no developer, API or integration page at all, api.impellaconnect.com
    is a private portal backend that answers every path with an nginx 502, and there is no SDK on
    npm or PyPI and no Abiomed-named GitHub organisation with a single public first-party repo.
  evidence:
  - url: https://www.heartrecovery.com/en-us
    status: 200
  - url: https://www.heartrecovery.com/en-us/sitemap.xml
    status: 200
  - url: https://www.heartrecovery.com/openapi.json
    status: 404
  - url: https://www.heartrecovery.com/.well-known/api-catalog
    status: 404
  - url: https://www.impellaconnect.com/openapi.json
    status: 200
  - url: https://api.impellaconnect.com/openapi.json
    status: 502
  - url: https://api.impellaconnect.com/api-docs
    status: 404
  - url: https://api.github.com/orgs/Abiomed/repos
    status: 200
  checked: '2026-09-06'